Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00726271 · ClinicalTrials.gov registry record · NA

Pilot Study of Dietary Modification of Appetite Set Point in Obesity

A NA study, sponsored by State University of New York - Upstate Medical University.

Terminated
Registry status
NA
Development phase
50
Enrollment target

NCT00726271: Clinical Trial NA study, sponsored by State University of New York - Upstate Medical University.

NCT00726271 is a NA study that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00726271, a NA study, was terminated before completion, sponsored by State University of New York - Upstate Medical University.

TERMINATED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

An innovative dietary approach to obesity, based on the set-point theory of body weight and associative learning, was developed by Seth Roberts. Roberts's approach focuses on dissociating flavor and calories by consuming small amounts of very bland but calorie-dense foods such as extra-light olive oil between meals. Roberts believes that the dissociation between flavor and calories lowers the body weight's set point, suppressing appetite and thereby inducing weight loss without causing hunger. Studying the feasibility of this approach is particularly relevant to patients taking drugs that cause increased appetite and weight gain as a side effect, as increased hunger makes the usual calorie restriction approach even more difficult than it normally is. Low-income people have a diet higher in prepackaged standardized foods, which may be one contributing factor to their higher risk of developing obesity. Specific Aims * To test the acceptance of, and the patients' compliance rate to, the Shangri-La Diet * To ascertain whether a controlled clinical trial of the Shangri-La Diet would be feasible. * To see if the weight loss documented anecdotally in many people is reproducible in patients from low-income areas who are overweight and taking prescribed medications associated with increased appetite and weight gain. Analysis: The primary end point will be acceptability of the dietary intervention as measured by the final interview and the evaluation form-is this something patients would be willing to do over the long term? This will help determine whether a controlled trial of the dietary intervention would be feasible, and provide information needed to design such a trial. Secondary outcomes will be changes in the participants' weight, waist measurements, anxiety, and depression scores

Interventions

  • DIETARY_SUPPLEMENT light olive oil, fish oil capsules, flax seed oil capsules

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-06
Est. Completion 2008-09
Phase NA

Why NCT00726271 stopped before completion

NCT00726271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which light olive oil, fish oil capsules, flax seed oil capsules is the first listed.

NCT00726271 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00726271 about?

NCT00726271 is a clinical study titled "Pilot Study of Dietary Modification of Appetite Set Point in Obesity". An innovative dietary approach to obesity, based on the set-point theory of body weight and associative learning, was developed by Seth Roberts. Roberts's approach focuses on dissociating flavor and calories by consuming small amounts of very bland but calorie-dense foods such as extra-light olive o...

What is the current status of trial NCT00726271?

This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2008-06. Estimated completion is 2008-09.

What interventions are being tested in trial NCT00726271?

The interventions under investigation include: light olive oil, fish oil capsules, flax seed oil capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00726271?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00726271's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00726271, the US trial registry maintained by the National Library of Medicine. NCT00726271 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.